Fig. 4. Individual loperamide plasma concentration–time curves for the 48-h period after the administration of loperamide (32 mg) and either placebo ( black dotted line ) or tariquidar ( gray solid line ). Loperamide plasma concentrations were not available for subject 1 after the 12-h time point.